[Federal Register Volume 77, Number 141 (Monday, July 23, 2012)]
[Notices]
[Pages 43096-43097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-17791]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on August 16, 2012, from 9:30 to 11:30 a.m. 
at 31 Center Drive on the NIH campus, Building 31C, Conference Room 6. 
The meeting is open to the public.

DATES: August 16, 2012, from 9:30 to 11:30 a.m.

ADDRESSES: National Institutes of Health, 31 Center Drive, Building 
31C, Conference Room 6C, Bethesda, MD 20892.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or 
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes 
Mellitus Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; Fax: 301-480-6741; email: [email protected].

SUPPLEMENTARY INFORMATION: The DMICC facilitates cooperation, 
communication, and collaboration on diabetes among government entities. 
DMICC meetings, held several times a year, provide an opportunity for 
members to learn about and discuss current and future diabetes programs 
in DMICC member organizations and to identify opportunities for 
collaboration. The August 16, 2012, DMICC meeting will focus on 
``Diabetes, Dementia, and Alzheimer's Disease.''
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written

[[Page 43097]]

comments with the Committee by forwarding their statement to the 
contact person listed on this notice. The statement should include the 
name, address, telephone number and when applicable, the business or 
professional affiliation of the interested person. Because of time 
constraints for the meeting, oral comments will be allowed on a first-
come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Dated: July 17, 2012.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2012-17791 Filed 7-20-12; 8:45 am]
BILLING CODE 4140-01-P